Cormorant Asset Management
Investment firm focused on innovative biotech, MedTech and life science companies in both public and private markets.
Boston, United States · 73+ investments · 65 portfolio companies
- Headquarters
- Boston, United States
- Founded
- 2013
- Website
- cormorant-capital.com
- AUM
- $3.0B
- Portfolio Companies
- 65
- Total Investments
- 73
- Last Investment
- Feb 2026
- Geographic Focus
- United States
Investment Thesis
Cormorant Asset Management is a Hedge Fund firm based in Boston, United States. It has made 73 investments in Biotech and Healthcare, including Arkuda Therapeutics, GreenLight Bio and Edgewise Therapeutics.
Portfolio65
Co-investors24
Sign up to view co-investors
24 co-investors across 148 shared portfolio companies — who they back alongside, and how often they lead.
Venture Capital ×17 · Hedge Fund ×3 · Corporate VC ×2 · 105 shared rounds
Investment History
Sign up to view investment history
Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.
Your firm? Embed this profile
Add the live badge to your site — it stays current as your portfolio data updates.
<a href="https://indexed.vc/investors/cormorant-asset-management"><img src="https://indexed.vc/api/badge/investor/cormorant-asset-management" alt="Cormorant Asset Management on Indexed.vc" width="260" height="76" /></a>